Citadel Advisors’s AMN Healthcare AMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.26M | Sell |
68,500
-25,400
| -27% | -$483K | ﹤0.01% | 7157 |
|
|
2025
Q4 | $1.48M | Sell |
93,900
-400
| -0.4% | -$7.14K | ﹤0.01% | 6539 |
|
|
2025
Q3 | $1.83M | Buy |
94,300
+23,700
| +34% | +$463K | ﹤0.01% | 6257 |
|
|
2025
Q2 | $1.46M | Buy |
70,600
+13,600
| +24% | +$283K | ﹤0.01% | 6320 |
|
|
2025
Q1 | $1.39M | Sell |
57,000
-32,400
| -36% | -$832K | ﹤0.01% | 6231 |
|
|
2024
Q4 | $2.14M | Buy |
89,400
+25,100
| +39% | +$797K | ﹤0.01% | 5486 |
|
|
2024
Q3 | $2.73M | Buy |
64,300
+19,400
| +43% | +$1.02M | ﹤0.01% | 4961 |
|
|
2024
Q2 | $2.3M | Sell |
44,900
-15,100
| -25% | -$856K | ﹤0.01% | 5058 |
|
|
2024
Q1 | $3.75M | Buy |
60,000
+37,600
| +168% | +$2.56M | ﹤0.01% | 4412 |
|
|
2023
Q4 | $1.68M | Sell |
22,400
-41,100
| -65% | -$2.94M | ﹤0.01% | 5682 |
|
|
2023
Q3 | $5.41M | Buy |
63,500
+6,500
| +11% | +$616K | ﹤0.01% | 3532 |
|
|
2023
Q2 | $6.22M | Buy |
57,000
+22,800
| +67% | +$2.16M | ﹤0.01% | 3313 |
|
|
2023
Q1 | $2.84M | Buy |
34,200
+6,100
| +22% | +$574K | ﹤0.01% | 4735 |
|
|
2022
Q4 | $2.89M | Sell |
28,100
-39,300
| -58% | -$4.53M | ﹤0.01% | 4802 |
|
|
2022
Q3 | $7.14M | Sell |
67,400
-78,600
| -54% | -$8.62M | ﹤0.01% | 3285 |
|
|
2022
Q2 | $16M | Buy |
146,000
+49,500
| +51% | +$4.9M | ﹤0.01% | 2087 |
|
|
2022
Q1 | $10.1M | Buy |
96,500
+35,600
| +58% | +$3.7M | ﹤0.01% | 2949 |
|
|
2021
Q4 | $7.45M | Buy |
60,900
+33,800
| +125% | +$3.75M | ﹤0.01% | 3600 |
|
|
2021
Q3 | $3.11M | Buy |
27,100
+5,300
| +24% | +$562K | ﹤0.01% | 5273 |
|
|
2021
Q2 | $2.11M | Buy |
21,800
+12,400
| +132% | +$1.08M | ﹤0.01% | 6478 |
|
|
2021
Q1 | $693K | Sell |
9,400
-3,100
| -25% | -$230K | ﹤0.01% | 8967 |
|
|
2020
Q4 | $853K | Sell |
12,500
-24,300
| -66% | -$1.58M | ﹤0.01% | 7126 |
|
|
2020
Q3 | $2.15M | Buy |
36,800
+9,200
| +33% | +$484K | ﹤0.01% | 4585 |
|
|
2020
Q2 | $1.25M | Buy |
27,600
+5,400
| +24% | +$258K | ﹤0.01% | 5415 |
|
|
2020
Q1 | $1.28M | Buy |
22,200
+4,500
| +25% | +$308K | ﹤0.01% | 4892 |
|
|
2019
Q4 | $1.1M | Buy |
17,700
+1,300
| +8% | +$76.9K | ﹤0.01% | 5416 |
|
|
2019
Q3 | $944K | Sell |
16,400
-2,900
| -15% | -$160K | ﹤0.01% | 5698 |
|
|
2019
Q2 | $1.05M | Sell |
19,300
-36,700
| -66% | -$1.86M | ﹤0.01% | 5625 |
|
|
2019
Q1 | $2.64M | Buy |
56,000
+43,500
| +348% | +$2.41M | ﹤0.01% | 4003 |
|
|
2018
Q4 | $708K | Sell |
12,500
-14,000
| -53% | -$785K | ﹤0.01% | 5851 |
|
|
2018
Q3 | $1.45M | Buy |
26,500
+18,300
| +223% | +$1.05M | ﹤0.01% | 4916 |
|
|
2018
Q2 | $481K | Sell |
8,200
-1,800
| -18% | -$107K | ﹤0.01% | 6433 |
|
|
2018
Q1 | $568K | Buy |
+10,000
| New | +$544K | ﹤0.01% | 5681 |
|
|
2017
Q2 | – | Sell |
-11,900
| Closed | -$483K | – | 7424 |
|
|
2017
Q1 | $483K | Sell |
11,900
-7,200
| -38% | -$282K | ﹤0.01% | 5080 |
|
|
2016
Q4 | $734K | Sell |
19,100
-7,700
| -29% | -$263K | ﹤0.01% | 4312 |
|
|
2016
Q3 | $854K | Buy |
26,800
+11,000
| +70% | +$418K | ﹤0.01% | 4038 |
|
|
2016
Q2 | $632K | Buy |
15,800
+7,100
| +82% | +$263K | ﹤0.01% | 4172 |
|
|
2016
Q1 | $292K | Sell |
8,700
-9,400
| -52% | -$269K | ﹤0.01% | 5127 |
|
|
2015
Q4 | $562K | Buy |
18,100
+10,300
| +132% | +$305K | ﹤0.01% | 4312 |
|
|
2015
Q3 | $234K | Buy |
7,800
+500
| +7% | +$16.5K | ﹤0.01% | 5927 |
|
|
2015
Q2 | $231K | Buy |
7,300
+1,400
| +24% | +$36.6K | ﹤0.01% | 6126 |
|
|
2015
Q1 | $136K | Buy |
+5,900
| New | +$122K | ﹤0.01% | 6582 |
|
|
2014
Q4 | – | Sell |
-500
| Closed | -$8K | – | 8459 |
|
|
2014
Q3 | $8K | Sell |
500
-1,800
| -78% | -$25.6K | ﹤0.01% | 7799 |
|
|
2014
Q2 | $28K | Sell |
2,300
-600
| -21% | -$7.18K | ﹤0.01% | 7106 |
|
|
2014
Q1 | $40K | Buy |
2,900
+2,400
| +480% | +$34.5K | ﹤0.01% | 6910 |
|
|
2013
Q4 | $7K | Sell |
500
-500
| -50% | -$6.77K | ﹤0.01% | 6774 |
|
|
2013
Q3 | $14K | Sell |
1,000
-1,100
| -52% | -$16.2K | ﹤0.01% | 6364 |
|
|
2013
Q2 | $30K | Buy |
+2,100
| New | +$29.5K | ﹤0.01% | 5896 |
|
Other funds holding AMN
VCM
VPM
Citadel Advisors's AMN Position: Q1 2026 in Review
Citadel Advisors reduced its AMN Healthcare (AMN) stake by 27% in Q1 2026, selling an estimated $2.72M and leaving 378,564 shares worth $6.94M. The position accounts for ﹤0.01% of the portfolio, ranked #3823.
Citadel Advisors first reported a position in AMN in Q2 2013 and has held it in 44 quarters since. The position peaked at $44.3M in Q2 2023. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.
- Citadel Advisors held 378,564 shares of AMN Healthcare worth $6.94M as of Q1 2026.
- Citadel Advisors sold 143,156 AMN Healthcare shares in Q1 2026, an estimated $2.72M.
- AMN Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3823 holding.
- Citadel Advisors first reported a position in AMN Healthcare in Q2 2013 and has held it in 44 quarters since.
- Citadel Advisors's AMN Healthcare position peaked at $44.3M in Q2 2023.
- 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.